Profiel
Valeria Cnossen is currently the Executive Vice President & General Counsel at Galapagos NV.
Prior to her current position, she served as the Head-Legal & Compliance at Crucell NV and as the General Counsel-Consumer Health Group at Johnson & Johnson Consumer NV.
Actieve functies van Valeria Cnossen
Bedrijven | Functie | Begin |
---|---|---|
GALAPAGOS NV | General Counsel | 01-01-2023 |
Eerdere bekende functies van Valeria Cnossen
Bedrijven | Functie | Einde |
---|---|---|
Johnson & Johnson Consumer NV | Corporate Officer/Principal | - |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Compliance Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GALAPAGOS NV | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Johnson & Johnson Consumer NV |